Abstract
Objective
This study investigates the clinical and demographic characteristics of familial Mediterranean fever (FMF) patients with and without amyloidosis.
Patients and methods
The clinical data of 503 patients with FMF (females:males 250:253) were reviewed. Fifty of these patients had amyloidosis (f:m 23:27).
Results
The ages of attack onset in patients with and without amyloidosis were 7.8±6.2 and 11.1±8.5, respectively (P<0.05). The time between disease onset and diagnosis was longer in patients with amyloidosis than those without (187.6±99.4 months and 132.5±110.2 months, respectively, P<0.001). More patients in the amyloidosis group had positive family histories of FMF (68% vs 54%, P<0.05). The frequencies of chest pain (78% vs 51%, P<0.001), arthritis ( 80% vs 60%, P<0.01), and erysipelas-like erythema (44% vs 16%, P<0.001) were higher in the amyloidosis group.
Conclusion
In the amyloidosis group, FMF-related manifestations of chest pain, arthritis, and erysipelas-like erythema are more frequent. Our results also support that long periods between disease onset and diagnosis are associated with a high risk of developing amyloidosis.
Similar content being viewed by others
References
Sohar E, Gafni J, Pras M, Heller J (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253
Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664
Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and the treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005
Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934
Pras M, Bronshpigel N, Zemer D, Gafni J (1982) Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 150:22–26
Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26:612–627
Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623
Ozdogan H, Arisoy N, Kasapcopur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327
Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, Tastan H, Kocak H, Ozkaya N, Elhan AH (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 39:67–72
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–85
Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mondjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67:1136–1143
Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A (2003) Male sex coupled with articular manifestations causes a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30:308–312
Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155
Kastner DL (2001) Intermittent and periodic arthritic syndromes. In: Koopman WJ (ed) Arthritis and allied conditions. A textbook of rheumatology, 14th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1400–1437
Pras M, Kastner DL (2000) Familial Mediterranean fever. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London 5:23.1–23.4
Ozdemir AI, Cavit S (1969) Familial Mediterranean fever among the Turkish people. Am J Gastroenterol 51:311–316
Ozer FL, Kaplaman E, Zileli S (1971) Familial Mediterranean fever in Turkey: a report of 20 cases. Am J Med 50:336–339
Dilsen N, Koniçe M, Aral O, Öcal L (1990) Amyloidosis associated with familial Mediterranean fever. The first international symposium on recurrent hereditary polyserositis. Amman, Jordan. Abstract book, pp 33–34
Yazici H, Ozdogan H (1997) Familial Mediterranean fever in Turkey. In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 66–71
Grateau G (2000) The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol 12:61–64
Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6:95–97
Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S (1999) MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694 V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88–97
Shohat M, Magal N, Shohat T, Chen X, Mimouni A, Lotan R (1999) Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7:287–292
Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R (1999) Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103:70
Pras E, Langevitz P, Livneh A, Zemer D, Migdal A, Padeh S, Lubetzky A, Aksentijevich I, Centola M, Zaks N, Deng Z, Sood R, Kastner DL, Pras M (1997) Genotype-phenotype correlation in familial Mediterranean fever (a preliminary report). In: Sohar E, Gafni J, Pras M (eds) Familial Mediterranean fever. First international conference. Freund, London, pp 260–264
Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1–6
Kone Paut I, Dubue M, Sportouch J, Minodier P, Garnier JM, Touıtou I (2000) Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology 39:1275–1279
Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE (2000) Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 20:1703–1707
Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis. J Nephrol 16:431–434
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cefle, A., Kamali, S., Sayarlioglu, M. et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 25, 442–446 (2005). https://doi.org/10.1007/s00296-004-0471-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0471-z